Archive - August 2018
AstraZeneca’s Lupus treatment misses mark in trial
Social care crisis looms as demand to double by 2035
Pfizer abandons antibody for Duchenne
Bayer wins US nod for Jivi
Severe asthma patients to get ‘life-changing’ procedure on NHS
US approves MSD HIV drugs Delstrigo and Pifeltro
Alnylam’s RNA therapy Onpattro bags EU nod
Shire completes sale of oncology franchise to Servier
